Skip to content
lifestyle.toptraveltrends.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
August 6, 2026
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
April 24, 2026
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey’s Aquanil Brand for Sensitive Skin
March 18, 2026
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
February 11, 2026